This company listing is no longer active
5I0 Stock Overview
Engages in the design, assembly, and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases in Singapore. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
QT Vascular Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.005 |
| 52 Week High | S$0.013 |
| 52 Week Low | S$0.003 |
| Beta | 1.53 |
| 1 Month Change | 25.00% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | 66.67% |
| 5 Year Change | -72.22% |
| Change since IPO | -98.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5I0 | SG Medical Equipment | SG Market | |
|---|---|---|---|
| 7D | 0% | -14.3% | 0.3% |
| 1Y | 0% | -10.7% | 14.1% |
Return vs Industry: 5I0 exceeded the SG Medical Equipment industry which returned -46.7% over the past year.
Return vs Market: 5I0 matched the SG Market which returned -0.1% over the past year.
Price Volatility
| 5I0 volatility | |
|---|---|
| 5I0 Average Weekly Movement | 38.3% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SG Market | 14.1% |
| 10% least volatile stocks in SG Market | 3.1% |
Stable Share Price: 5I0 has not had significant price volatility in the past 3 months.
Volatility Over Time: 5I0's weekly volatility (38%) has been stable over the past year, but is still higher than 75% of SG stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Thomas Tan | quantumhealthcare.com.sg |
QT Vascular Ltd., together with its subsidiaries, engages in the design, assembly, and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The company provides coronary products, including Chocolate percutaneous transluminal coronary angioplasty (PTCA) balloon catheter to reduce vessel trauma by providing balloon inflation; and Glider PTCA balloon catheter for the treatment of various complex lesions. It also offers Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter for atraumatic dilatation in the treatment of blocked arteries; Chocolate Touch PTA balloon catheter to treat peripheral vascular disease; GliderfleX PTA balloon catheter for treating distal peripheral vessels; and GliderXtreme PTA balloon catheter that targets complex lesions in the distal peripheral vasculature.
QT Vascular Ltd. Fundamentals Summary
| 5I0 fundamental statistics | |
|---|---|
| Market cap | S$34.47m |
| Earnings (TTM) | -S$5.43m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-6.4x
P/E RatioIs 5I0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5I0 income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$3.91m |
| Earnings | -US$3.91m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00055 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -18.7% |
How did 5I0 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/07/28 07:32 |
| End of Day Share Price | 2022/07/22 00:00 |
| Earnings | 2021/12/31 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Quantum Healthcare Limited is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sin Ng | CGS International |
| null null | UOB Kay Hian Research Pte Ltd |
| Andrea Isabel Co | UOB Kay Hian Research Pte Ltd |